Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study.
about
Alzheimer's disease: current pharmacotherapy in the context of patient and family needs.Recommendations for the management of behavioral and psychological symptoms of dementia.Cholinesterase inhibitors for the treatment of Alzheimer's disease in the elderly.Cholinergic therapy for neuropsychiatric symptoms in neurologic disorders.Pharmacotherapy of behavioral and psychological symptoms of dementia: time for a different paradigm?Drugs for dementia: the first year. An audit of prescribing practice.Depressive syndromes in dementia.Cholinesterase inhibitors for behavioral disturbance in dementia.Pharmacological and Nonpharmacological Treatment for Apathy in Alzheimer Disease : A systematic review across modalitiesDonepezil use in Alzheimer disease.Cognitive and motor symptoms in dementia: focus on dementia with Lewy bodies.Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine.Pharmacologic therapy of dementia with Lewy bodies.Behavior problems in demented nursing home residents: a multifaceted approach to assessment and management.Independence of changes in behavior from cognition and function in community-dwelling persons with Alzheimer's disease: a factor analytic approach.A critical review of cholinesterase inhibitors as a treatment modality in Alzheimer's disease.Treating Psychotic Symptoms in Elderly Patients.NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer's Disease.Role of Cholinesterase Inhibitors in Managing Behavioral Problems in Alzheimer's DiseaseFrontal-subcortical circuitry and behavior.Different apathy clinical profile and neural correlates in behavioral variant frontotemporal dementia and Alzheimer's disease.Treating Alzheimer's disease. Pharmacologic options now and in the near future.Pharmacologic treatment of agitation in dementia: a comprehensive review.Clock drawing and frontal lobe behavioral effects of memantine in Alzheimer's disease: a rater-blinded study.A 6-month open-label study of the effectiveness and tolerability of galantamine in patients with Alzheimer's disease.Pilot study of pharmacological treatment for frontotemporal dementia: effect of Yokukansan on behavioral symptoms.Determining the minimum clinically important differences for outcomes in the DOMINO trial.Efficacy of metrifonate in improving the psychiatric and behavioral disturbances of patients with Alzheimer's disease.A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.Galantamine and behavior in Alzheimer disease: analysis of four trials.Gender, aggression and serotonergic function are associated with response to sertraline for behavioral disturbances in Alzheimer's disease.The efficacy of galantamine in the treatment of Alzheimer's disease: comparison of patients previously treated with acetylcholinesterase inhibitors to patients with no prior exposure.Cholinesterase-inhibitor therapy for dementia: novel clinical substrates and mechanisms for treatment response.Emergent psychopathology in Alzheimer's disease patients over 12 months associated with functional, not cognitive, changes.Do vascular lesions and related risk factors influence responsiveness to donepezil chloride in patients with Alzheimer's disease?Measuring change in psychiatric symptoms using the Neuropsychiatric Inventory: Nursing Home version.Negative symptoms in the elderly patient with dementia.[Treatment of Alzheimer' disease: critical evaluation of the use of anticholinesterase]Tacrine therapy is associated with reduced mortality in nursing home residents with dementia.
P2860
Q30310930-E45C4C45-40C5-4B43-837E-B7C840D612A2Q30327961-1C32CA30-72AA-4AF1-AEAE-973B69E06B97Q33885924-208E2B0D-D5E8-44D7-B4A0-46FA52A054BDQ34108192-EE2F7645-9318-43C6-BD04-05AA44100A7FQ34146983-BBF2EDF8-18D1-44C7-812B-F9D47BFEFEC2Q34150502-6FBC30A7-FC1F-4E74-9CED-2CE11631EDD6Q34174245-7E9C2E0D-5C74-4A10-93CF-66E6918ED4CDQ34251448-2938054B-5702-4479-B0AD-19770A642EF2Q34552380-777F575F-465E-49A3-8950-94DE1E2E01CCQ34663361-78E66B28-DB37-4602-8606-A3794A8B954BQ34957392-E5D7B246-8EE6-4800-A9D7-A47D940278AAQ34987695-4E1C3395-533B-4588-A519-99851CF279B9Q35029479-10E0E9F3-9170-43F4-833A-10CF10C7A3F0Q35036002-7393DA81-A176-4E1A-894D-26BB80BB220BQ35226430-6DFC591D-8084-484E-B2BC-F9C9DEDDFA5FQ35236228-0121531B-DFCC-4B6E-952B-C5E31A6C04D8Q35666369-7F16B871-C7B5-440E-B9EA-5D9F674EF527Q36310524-6D67E94C-170C-4BE0-AD9B-D50C46D3ED4CQ36562125-0EAF4EDA-32AB-4691-A554-8F07B3FB18A5Q36922121-9EE6A541-90BC-46E7-9160-A4EA6F1AD451Q38940217-F5C50BC6-5809-4E0B-8474-17914336E882Q39455416-0F2A94DD-98A4-4174-A970-7A3EC5410134Q41169288-8600951F-C775-4698-8469-2A7E94DFDC5DQ42610768-7A5351A7-9B5A-4D32-8425-17B3ECB5DAADQ42623834-03093249-7606-4BCD-BDAE-CA8D399DECE9Q42659690-2594140F-7F2A-48A9-8792-D7F4BD6F5644Q42675662-E5606C42-BBBD-4079-B80D-A19062A8CF07Q43648552-1F7080AC-6F44-4F8A-A9A1-231586E58676Q43885713-7DAFBE99-D9FB-4343-A660-EE8230462779Q43938849-EB97D43C-D8EF-4A10-BBA2-C08223A36C9DQ44060139-11B09018-1DF6-4DC2-87DD-7BD120FC63F5Q44389242-2BF5B7A8-E3FD-4104-95CC-AE4DF5920FC2Q44807722-19E6C232-243D-4B88-A7FC-3946104D957BQ46079295-C86EAA39-9D73-4FEA-80BC-2AA78F35419AQ46439014-EE998C56-EC4C-425F-BAED-0CE489E1A0AEQ51957248-825FC522-EF7B-43B5-9D12-5BFDF4FF8597Q51961408-094B43C7-C1F5-499B-94A0-296F8EEC86EDQ52532967-401EB362-3209-49BA-86AA-98A40A711E2DQ53352657-9C1A0D0F-175A-4F25-9C6C-DC89E265595E
P2860
Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study.
@en
Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study.
@nl
type
label
Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study.
@en
Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study.
@nl
prefLabel
Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study.
@en
Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study.
@nl
P2093
P2860
P1476
Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study.
@en
P2093
D Christine
D I Kaufer
J L Cummings
P2860
P356
10.1177/089198879600900101
P577
1996-01-01T00:00:00Z